Insmed Inc. buy Morgan Stanley
Start price
30.03.26
/
50%
€133.00
Target price
30.03.27
€184.08
Performance (%)
-19.01%
Price
21.08.26
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -19.01%. This prediction currently runs until 30.03.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 1.985% | 1.985% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.
Ratings data for INSM provided by MarketBeat